阻塞性睡眠呼吸暂停的药理疗法:系统性审查和元分析
Maria Luísa Nobre1, Ayane Cristine Alves Sarmento2, Priscila Farias de Oliveira3
1Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.
Clinics (Sao Paulo, Brazil)
|February 11, 2024
概括
药物治疗对阻塞性睡眠呼吸暂停 (OSA) 有希望. 组合疗法,如阿托莫克西丁和氧丁宁,显著降低了呼吸暂停-呼吸暂停指数 (AHI). 需要进一步的研究来确认长期的安全性和有效性.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种常见的疾病,在睡眠期间重复出现上呼吸道崩.
- 目前的CPAP等治疗方法存在局限性,需要探索替代药物治疗方法.
研究的目的:
- 系统地审查和分析药物疗法的有效性,以减少OSA患者的呼吸暂停 - 呼吸暂停指数 (AHI).
主要方法:
- 在多个数据库 (PubMed,Embase,Scopus等) 进行了全面的文献搜索. 对于随机临床试验,截至2023年2月.
- 数据提取和偏差风险评估由两位作者独立进行,并使用RevMan 5.4.4进行元分析.
主要成果:
- 对29项涉及11种药物的研究进行的元分析显示,使用多种药物显著降低了AHI.
- 阿托莫克西丁加上氧丁宁显示平均AHI差异为-7.71.1.
- 与安慰剂相比,多尼佩西尔,氧酸盐和特拉佐也在统计学上显著地减少了AHI.
结论:
- 与诺亚上腺和抗肌类药物的联合治疗为OSA药物治疗提供了一个有前途的途径.
- 未来的研究应该集中在确定患者内型和进行长期研究,以评估这些药物治疗的安全性和持续有效性.
相关概念视频
Sleep Apnea
156
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
156
Management of Insomnia
248
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
248
Sedatives and Hypnotics Drugs: Miscellaneous Agents
175
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
175
Sleepwalking and Sleep Talking
161
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
161
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
803
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
803


